KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Current Deferred Revenue (2016 - 2023)

Exelixis (EXEL) has 13 years of Current Deferred Revenue data on record, last reported at $13.4 million in Q1 2023.

  • For Q1 2023, Current Deferred Revenue changed N/A year-over-year to $13.4 million; the TTM value through Mar 2023 reached $13.4 million, changed N/A, while the annual FY2022 figure was $14.1 million, 15.0% down from the prior year.
  • Current Deferred Revenue reached $13.4 million in Q1 2023 per EXEL's latest filing, down from $14.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $16.6 million in Q4 2021 and bottomed at $2.4 million in Q1 2019.
  • Average Current Deferred Revenue over 5 years is $10.8 million, with a median of $13.4 million recorded in 2022.
  • The widest YoY moves for Current Deferred Revenue: up 198.52% in 2021, down 15.93% in 2021.
  • A 5-year view of Current Deferred Revenue shows it stood at $2.4 million in 2019, then surged by 177.61% to $6.6 million in 2020, then soared by 150.96% to $16.6 million in 2021, then dropped by 15.0% to $14.1 million in 2022, then dropped by 5.02% to $13.4 million in 2023.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $13.4 million in Q1 2023, $14.1 million in Q4 2022, and $13.4 million in Q3 2022.